An exploratory analysis between dynamic change of metabolic syndrome and type 2 diabetes in a Chinese cohort

被引:0
作者
Zhou, Hui [1 ,2 ,6 ]
Yang, Chen [1 ,3 ]
Guo, Zhi-rong [1 ,6 ]
Hu, Xiao-Shu [4 ]
Xu, Yong [1 ]
Zhou, Zhen-Yuan [5 ]
机构
[1] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China
[2] Ctr Dis Control & Prevent, Suzhou, Jiangsu, Peoples R China
[3] Ctr Dis Control Xiangcheng Dist Suzhou City, Suzhou, Jiangsu, Peoples R China
[4] Hlth Bur Jiangsu Prov, Nanjing, Jiangsu, Peoples R China
[5] Changshu Ctr Dis Control & Prevent, Changchu City, Peoples R China
[6] Grad Workstat Soochow Univ, Ctr Dis Control & Prevent, Suzhou, Peoples R China
关键词
Diabetes; Metabolic syndrome (MS); Cohort study; Dynamic change; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ALTERNATIVE DEFINITIONS; PREDICTOR; CHOLESTEROL; MELLITUS; GLUCOSE; RISKS;
D O I
10.1007/s13410-015-0332-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to analyze the impact of dynamic changes of the metabolic syndrome (MS) on the development of type 2 diabetes (T2DM). Subjects (3461) were recruited from a cohort study of Prevention of Multiple Metabolic disorders and MS in Jiangsu of China (PMMJS) with a follow-up of 3.8 years. The associations between the relative risk (RR) of T2DM and the dynamic changes (difference, the value at first follow-up subtract the value at baseline) of MS component numbers and each MS component were analyzed by using Cox regression model. The total incidence standardized rate of T2DM was 4.67 %. The incidence standardized rates of T2DM in the group of baseline MS-/first follow-up MS-, baseline MS+/first follow-up MS-, baseline MS-/first follow-up MS+, and baseline MS+/first follow-up MS+ were 2.16, 2.88, 9.56, and 10.75 % separately. MS subject numbers in four groups was significantly associated with risk of T2DM (aRR, 1.85; 95%CI, 1.62-2.09). Individuals with highest quartile of difference of MS component number (DMSCN) were approximately 3.92 times to develop T2DM than individuals with lowest quartile of DMSCN. After adjustment for the confounding factors, difference of systolic blood pressure (SBP), waist circumference (WC), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), and fasting plasma glucose (FPG) showed significant associations with the incidence of T2DM. The dynamic changes of MS component numbers and four groups on the basis of baseline and first follow-up MS and/or non-MS had the prediction ability of T2DM. In Chinese, the dynamic change of MS was a useful prediction factor for T2DM.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 27 条
  • [1] [Anonymous], COMM MAJ FIG 2000 PO
  • [2] The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study
    Cameron, A. J.
    Magliano, D. J.
    Zimmet, P. Z.
    Welborn, T. A.
    Colagiuri, S.
    Tonkin, A. M.
    Shaw, J. E.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2008, 264 (02) : 177 - 186
  • [3] The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius
    Cameron, A. J.
    Zimmet, P. Z.
    Soderberg, S.
    Alberti, K. G. M. M.
    Sicree, R.
    Tuomilehto, J.
    Chitson, P.
    Shaw, J. E.
    [J]. DIABETIC MEDICINE, 2007, 24 (12) : 1460 - 1469
  • [4] Development of diabetes in Chinese with the metabolic syndrome - A 6-year prospective study
    Cheung, Bernard M. Y.
    Wat, Nelson M. S.
    Man, Yu Bun
    Tam, Sidney
    Thomas, G. Neil
    Leung, Gabriel M.
    Cheng, Chun Ho
    Woo, Jean
    Janus, Edward D.
    Lau, Chu Pak
    Lam, Tai Hing
    Lam, Karen S. L.
    [J]. DIABETES CARE, 2007, 30 (06) : 1430 - 1436
  • [5] The metabolic syndrome
    Eckel, RH
    Grundy, SM
    Zimmet, PZ
    [J]. LANCET, 2005, 365 (9468) : 1415 - 1428
  • [6] β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes:: A new analysis
    Ferrannini, E
    Gastaldelli, A
    Miyazaki, Y
    Matsuda, M
    Mari, A
    DeFronzo, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) : 493 - 500
  • [7] Metabolic syndrome and incident diabetes - Current state of the evidence
    Ford, Earl S.
    Li, Chaoyang
    Sattar, Naveed
    [J]. DIABETES CARE, 2008, 31 (09) : 1898 - 1904
  • [8] Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence
    Ford, ES
    [J]. DIABETES CARE, 2005, 28 (07) : 1769 - 1778
  • [9] Genuth S, 2003, DIABETES CARE, V26, P3160
  • [10] Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    Grundy, SM
    Cleeman, JI
    Daniels, SR
    Donato, KA
    Eckel, RH
    Franklin, BA
    Gordon, DJ
    Krauss, RM
    Savage, PJ
    Smith, SC
    Spertus, JA
    Costa, F
    [J]. CIRCULATION, 2005, 112 (17) : 2735 - 2752